Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors

Journal of Clinical Oncology

Volumn 13, Issue 7, 1995, Pages 1758-1767

  Tirelli, Umberto ^a   Errante, Domenico ^a   Dolcetti, Riccardo ^a   Gloghini, Annunziata ^a   Serraino, Diego ^a   Vaccher, Emanuela ^a   Franceschi, Silvia ^a   Boiocchi, Mauro ^a   Carbone, Antonino ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CD4 ANTIGEN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE MARROW TOXICITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTHERN BLOTTING;

EID: 0029061791     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.7.1758     Document Type: Article

References (48)

1. Ahmed T, Wormser GP, Stahl RE, et al: Malignant lymphomas in a population at risk for acquired immune deficiency syndrome. Cancer 60:719-723, 1987
2. Temple JJ, Andes WA: AIDS and Hodgkin's disease. Lancet 2:454-455, 1986
3. Roithmann S, Tourani JM, Andrieu JM: HIV-associated Hodgkin's disease: Report of 45 cases Eur J Cancer 27:S13, 1991 (abstr 46) (suppl 2)
4. Liff JM, Eley JW, Khabbaz RF, et al: HIV seropositivity and Hodgkin's lymphoma. VI Int Conference AIDS 2:378, 1990 (abstr)
5. Hessol NA, Katz MH, Liu JY, et al: Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 117:309-311, 1992
6. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41:1-13, 1992
7. Reynolds P, Saunders LD, Layefsky ME, et al: The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987 Am J Epidemiol 137:19-30, 1993
8. Rabkin CS, Biggar RJ, Horm JW: Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 47:692-696, 1991
9. Biggar RJ, Horm J, Goedert JJ, et al: Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 126:578-586, 1987
10. Ree HJ, Strauchen JA, Khan AA, et al: Human immunodeficiency virus-associated Hodgkin's disease: Clinico-pathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 67:1614-1621, 1991
11. Serraino D, Carbone A, Franceschi S, et al: Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin's disease in HIV infected patients Eur J Cancer 14:1948-1950, 1993
12. Andrieu JM, Roithmann S, Tourani JM, et al: Hodgkin's disease during HIV1 infection: The French Registry experience. Ann Oncol 4:635-641, 1993
13. Errante D, Zagonel V, Vaccher E, et al: Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Ann Oncol 5:S37-S40, 1994
14. Serrano M, Bellas C, Campo E, et al: Hodgkin's disease in patients with antibodies to human immunodeficiency virus: A study of 22 patients. Cancer 65:2248-2254, 1990
15. Knowles DM, Chamulak GA, Subar M, et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York Medical Center experience with 105 patients (1981-1986). Ann Intern Med 108:744-753, 1988
16. Lowenthal DA, Straus DJ, Campbell SW, et al: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61:2325-2337, 1988
17. Ames ED, Conjalka MS, Golberg AF, et al: Hodgkin's disease and AIDS. Twenty-three new cases and a review of the literature. Hematol Oncol Clin North Am 5:343-356, 1991
18. Gold JE, Altarac D, Ree HJ, et al: HIV-associated Hodgkin's disease: A clinical study of 18 cases and review of the literature. Am J Hematol 36:93-99, 1991
19. Pelstring RJ, Zellmer RB, Sulak LE, et al: Hodgkin's disease in association with human immunodeficiency virus infection: Pathologic and immunologic features. Cancer 67:1865-1873, 1991
20. Rubio R for the Cooperative Study Group of Malignancies associated with HIV infection of Madrid: Hodgkin's disease associated with human immunodeficiency virus infection. Cancer 73:2400-2407, 1994
21. Tirelli U, Errante D, Vaccher E, et al: Hodgkin's disease in 92 patients with HIV infection: The Italian experience. Ann Oncol 3:S69-S72, 1992
22. Uccini S, Monaldo F, Ruco LP, et al: High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1:1458, 1989
23. Uccini S, Monaldo F, Stoppacciaro A, et al: High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV positive patients. Int J Cancer 46:581-585, 1990
24. Moran CA, Tuur S, Angritt P, et al: Epstein-Barr virus in Hodgkin's disease from patients with human immunodeficiency virus infection. Mod Pathol 5:85-89, 1992
25. Audouin J, Diebold J, Pallesen G: Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 167:381-384, 1992
26. Serraino D, Franceschi S, Talamini R, et al: Socio-economic indicators, infectious diseases and Hodgkin's disease. Int J Cancer 47:352-357, 1991
27. Lukes RJ, Craver LF, Hall TC, et al: Report of the Nomenclature Committee. Cancer Res 26:1311, 1966
28. Lukes RJ, Butler JJ, Hicks EB: Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 19:317-344, 1966
29. Neiman RS: Current problems in the histopathologic diagnosis and classification of Hodgkin's disease, in Sommers SC, Rosen PP (eds): Pathology Annual. Collegeville, PA, Appleton-Century-Crofts 1978, pp 289-328
30. Ceccherini-Nelli L, De Re V, Viel A, et al: Ha-ras restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. Br J Cancer 56:1-5, 1987
31. Polach A, Hartl G, Zimber U, et al: A complete set of overlapping cosmid clones of M-ABA virus deerived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 27:279-288, 1984
32. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889, 1986
33. Flanagan JG, Rabbitts TH: The sequence of a human immunoglobulin epsilon heavy chain constant region gene and evidence for three non-allelic genes. EMBO J 5:655-660, 1982
34. Hieter PA, Maizel JV, Leder P: Evolution of human immunoglobulin kappa J region genes. J Biol Chem 257:1516-1522, 1982
35. Rabbitts TH, Forster A, Mattheus JG: The breakpoint of the Philadelphia chromosome 22 in chronic myeloid leukemia is distal to the immunoglobulin lambda light chain constant region genes. Mol Biol Med 1:11-19, 1983
36. Sims JE, Tunnacliffe A, Smith WJ, et al: Complexity of human T-cell antigen receptor chain constant- and variable-region genes. Nature 312:541-545, 1984
37. Diss TC, Peng H, Wotherspoon AC, et al: Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 169:291-295, 1993
38. De Vita S, Ferraccioli G, De Re V, et al: The polymerase chain reaction detect B cell clonalities in patients with Sjogren's syndrome and suspected malignant lymphoma. J Rheumatol 21:1497-1501, 1994
39. Saiki RK, Scharf S, Faloona F, et al: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, 1985
40. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36:1-158, 1987
41. De Vita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-885, 1970
42. Bonadonna G, Zucali R, Monfardini S, et al: Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide vs MOPP. Cancer 36:252-259, 1975
43. Zittoun R, Eghbali H, Audebert A, et al: Association d'epirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiotherapie dans les stades localises de la maladie de Hodgkin. Bull Cancer 74:151-157, 1987
44. Errante D, Tirelli U, Gastaldi R, et al: Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. Cancer 73:437-444, 1994
45. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
46. Mantel N: Evaluation of survival data and two new rank order statistics in its consideration. Cancer Chemother Rep 50:163-170, 1966
47. Carbone A, Gloghini A, Zanette I, et al: Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 422:39-45, 1993
48. Boyle MJ, Sewell WA, Sculley TB, et al: Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 78:3004-3011, 1991